𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventions

✍ Scribed by Andrew D. Siderowf; Robert G. Holloway; Matthew B. Stern


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
43 KB
Volume
15
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The effect of pregnancy in Parkinson's d
✍ Lisa M. Shulman; Alireza Minagar; William J. Weiner πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 23 KB πŸ‘ 1 views

Pregnancy in patients with Parkinson's disease (PD) is a rare occurrence. Previous reports based on retrospective analysis suggest that pregnancy may have a deleterious effect on PD. We describe the effects of pregnancy on the symptomatology of a 33-year-old woman with PD using quantitative neurolog

Neuroprotective effects of (Β±)-kavain in
✍ Nicole Schmidt; Boris Ferger πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 1 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

Societal value, the person trade-off, an
✍ Peter A. Ubel; Jeff Richardson; Paul Menzel πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

In a previous paper, it was argued that Societal Value measurement through person trade-off (PTO) elicitation offers a way to include the values of both general public and patients into cost-effectiveness analysis (CEA). It was said that patients' values could be used to estimate the effect that var